Impact of proton pump inhibitors on clinical outcomes in patients treated with a 6-or 24-month dual-antiplatelet therapy duration: Insights from the PROlonging Dual-antiplatelet treatment after Grading stent-induced Intimal hyperplasia studY trial

G Gargiulo; F (Frederico) Costa; Sara Ariotti; S Biscaglia; G Campo; G Esposito; S Leonardi; P Vranckx; S Windecker; Marco Valgimigli

doi:10.1016/j.ahj.2016.01.015

Impact of proton pump inhibitors on clinical outcomes in patients treated with a 6-or 24-month dual-antiplatelet therapy duration: Insights from the PROlonging Dual-antiplatelet treatment after Grading stent-induced Intimal hyperplasia studY trial

G Gargiulo, F (Frederico) Costa, Sara Ariotti, S Biscaglia, G Campo, G Esposito, S Leonardi, P Vranckx, S Windecker, Marco Valgimigli

Cardiology

Research output: Contribution to journal › Article › Academic › peer-review

56 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	95-102
Number of pages	8
Journal	American Heart Journal
Volume	174
DOIs	https://doi.org/10.1016/j.ahj.2016.01.015
Publication status	Published - 2016

Research programs

EMC COEUR-09

Access to Document

10.1016/j.ahj.2016.01.015

http://hdl.handle.net/1765/87561

Cite this

Gargiulo, G., Costa, F., Ariotti, S., Biscaglia, S., Campo, G., Esposito, G., Leonardi, S., Vranckx, P., Windecker, S., & Valgimigli, M. (2016). Impact of proton pump inhibitors on clinical outcomes in patients treated with a 6-or 24-month dual-antiplatelet therapy duration: Insights from the PROlonging Dual-antiplatelet treatment after Grading stent-induced Intimal hyperplasia studY trial. American Heart Journal, 174, 95-102. https://doi.org/10.1016/j.ahj.2016.01.015

@article{c365e0156ebe4ebb9a4ccb4044339e5a,

title = "Impact of proton pump inhibitors on clinical outcomes in patients treated with a 6-or 24-month dual-antiplatelet therapy duration: Insights from the PROlonging Dual-antiplatelet treatment after Grading stent-induced Intimal hyperplasia studY trial",

author = "G Gargiulo and Costa, {F (Frederico)} and Sara Ariotti and S Biscaglia and G Campo and G Esposito and S Leonardi and P Vranckx and S Windecker and Marco Valgimigli",

year = "2016",

doi = "10.1016/j.ahj.2016.01.015",

language = "Undefined/Unknown",

volume = "174",

pages = "95--102",

journal = "American Heart Journal",

issn = "0002-8703",

publisher = "Elsevier Inc.",

}

Gargiulo, G, Costa, F, Ariotti, S, Biscaglia, S, Campo, G, Esposito, G, Leonardi, S, Vranckx, P, Windecker, S & Valgimigli, M 2016, 'Impact of proton pump inhibitors on clinical outcomes in patients treated with a 6-or 24-month dual-antiplatelet therapy duration: Insights from the PROlonging Dual-antiplatelet treatment after Grading stent-induced Intimal hyperplasia studY trial', American Heart Journal, vol. 174, pp. 95-102. https://doi.org/10.1016/j.ahj.2016.01.015

Impact of proton pump inhibitors on clinical outcomes in patients treated with a 6-or 24-month dual-antiplatelet therapy duration: Insights from the PROlonging Dual-antiplatelet treatment after Grading stent-induced Intimal hyperplasia studY trial. / Gargiulo, G; Costa, F (Frederico); Ariotti, Sara et al.
In: American Heart Journal, Vol. 174, 2016, p. 95-102.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Impact of proton pump inhibitors on clinical outcomes in patients treated with a 6-or 24-month dual-antiplatelet therapy duration: Insights from the PROlonging Dual-antiplatelet treatment after Grading stent-induced Intimal hyperplasia studY trial

AU - Gargiulo, G

AU - Costa, F (Frederico)

AU - Ariotti, Sara

AU - Biscaglia, S

AU - Campo, G

AU - Esposito, G

AU - Leonardi, S

AU - Vranckx, P

AU - Windecker, S

AU - Valgimigli, Marco

PY - 2016

Y1 - 2016

U2 - 10.1016/j.ahj.2016.01.015

DO - 10.1016/j.ahj.2016.01.015

M3 - Article

C2 - 26995375

SN - 0002-8703

VL - 174

SP - 95

EP - 102

JO - American Heart Journal

JF - American Heart Journal

ER -

Gargiulo G, Costa F, Ariotti S, Biscaglia S, Campo G, Esposito G et al. Impact of proton pump inhibitors on clinical outcomes in patients treated with a 6-or 24-month dual-antiplatelet therapy duration: Insights from the PROlonging Dual-antiplatelet treatment after Grading stent-induced Intimal hyperplasia studY trial. American Heart Journal. 2016;174:95-102. doi: 10.1016/j.ahj.2016.01.015